ColemanMPFormanDBryantHet al. ICBP Module 1 Working Group. Cancer survival in Australia, Canada, Norway,Sweden, Denmark, and the UK, 1995-2007: an analysis of population-based cancer registry data. Lancet2011:377 (9760):127-38.
2.
BourkeLBoorjianSABrigantiAet al. Survivorship and Improving quality of life in men with prostate cancer. Eur Urol2015;68(3):374-83.
3.
MayerDKNekhlyudovLSnyderCFMerrillJKWollinsDSShulmanLN.American Society of clinical oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract2014;10(6):345-51.
4.
NCCN Guidelines version 2.2017.
5.
Linee Guida Associazione Italiana di Oncologia medica (AIOM)2017. Tumori dell’urotelio.
6.
KusakaAHatakeyamaSHosogoeSet al. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer. Med Oncol2017;34(5):90.
7.
American Urological Association (AUA), Version 2017.
8.
TranWSerioAMRajGVet al: Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance. J Urol2008; 179: 96-100.
9.
GiannariniGKesslerTMThoenyHCNguyenDPMeissnerCStuderUE. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?Eur Urol2010;58(4):486-94.
10.
VolkmerBGKueferRBartschGCJrGustKHautmannRE. Oncological follow-up after radical cystectomy for bladder cancer-is there any benefit?J Urol2009;181(4):1587-93; discussion 1593.
11.
PicozziSRicciCGaetaMet al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol2012;188(6):2046-54.
12.
SoukupVBabjukMBellmuntJet al. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur Urol2012; 62(2):290-302.
13.
SandersonKMCaiJMirandaGSkinnerDGSteinJP. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year follow-up. J Urol2007; 177: 2088-94.
14.
NieuwenhuijzenJAde VriesRRvan TinterenHet al. Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy. Eur J Surg Oncol2014;40(12):1677-85.
15.
MakRHHuntDShipleyWUet al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol2014Dec1;32(34):3801-9.
16.
EfstathiouJASpiegelDYShipleyWUet al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol2012;61(4):705-11.
